Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Multiple treatments work best for hair loss.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

HIV can cause unusual and severe skin problems that are hard to treat.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

New alopecia treatments aim for better results and fewer side effects.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Assessing newborn scalp hair can reveal important health information.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.